The Asia Pacific Dermatome Device Market would witness market growth of 6.3% CAGR during the forecast period (2023-2030).
Emerging countries will have more diabetics than developed ones by the year 2030. Obesity is caused by a lack of physical activity and a bad diet brought on by busy lifestyles, which also raises the risk of diabetes. Incidences of chronic wounds like foot ulcers (FUs) are also rising, which is driving up the demand for items used in wound debridement.
In many countries, the therapy of diabetic foot ulcers—whose annual prevalence is estimated to be between 4 and 10%—is also seen as a considerable burden on healthcare systems. The burden of type 2 diabetes will also continue to climb, which will raise the burden of chronic wounds, as key figures point to an accelerating rise in type 2 diabetes cases. As a result, the market will continue to grow in the years to come despite the proportion of diabetic patients increasing.
The Asia region is predicted to grow as medical tourism in developing countries increases. For instance, the Ministry of Tourism predicted that India would see 186,644 FTAs for medical reasons in 2020, or 7% of all FTAs, according to a report by the India Brand Equity Foundation (IBEF). The inexpensive cost of healthcare abroad, the healthcare provider's cultural characteristics, the common language, and certain procedures that are unavailable in the home country are the most frequently cited arguments for medical travel. As a result, this region offers the market profitable growth opportunities for the entire projection period.
The China market dominated the Asia Pacific Dermatome Device Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $17,260.8 Thousands by 2030. The Japan market is poised to grow at a CAGR of 5.7% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7% during (2023 - 2030).
Based on Application, the market is segmented into Chronic Burn Care Treatments, General Surgery, Plastic Surgery and Reconstructive Surgery & Others. Based on Product, the market is segmented into Powered Dermatome Device (Pneumatic, Battery Operated, and Electric), Knife Dermatome Device and Drum Dermatome Device. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Dermatology Clinics and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Dermatome Device Market is Projected to reach USD 235.9 Million by 2030, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Aesculap, Inc. (B. Braun Melsungen AG), Surtex Instruments Ltd., Richard Wolf GmbH, Shaanxi Xingmao Industry Co., Ltd., Aygun Surgical Instruments Co., Inc. (CEECAT Capital), Humeca BV (Holland Venture), Nouvag AG and Novo Surgical Inc.
By Application
By Product
By End Use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
